Plymouth appoint Austrian coach Miron Muslic to succeed Wayne Rooney
Novak Djokovic’s claim he ate ‘poisoned’ food in 2022 Melbourne hotel detention ‘possible but very unlikely’, experts say
One dead, two in hospital after knife-fight in Melbourne park
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Bizarre Australian mole even more unusual than first thought, new research reveals
MHRA authorises uses of Casgevy as a potential cure for sickle cell disease and beta thalassemia
Britain’s drugs regulator has approved a groundbreaking treatment for two painful and debilitating lifelong blood disorders, which works by “editing” the gene that causes them.
The Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light for Casgevy to be used to treat sickle cell disease and beta thalassemia.
More Stories
Bizarre Australian mole even more unusual than first thought, new research reveals
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton